Detalhe da pesquisa
1.
T cell hybrid immunity against SARS-CoV-2 in children: a longitudinal study.
EBioMedicine
; 105: 105203, 2024 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38896919
2.
Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12-17- year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccination.
Vaccine
; 42(12): 2951-2954, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38584057
3.
BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study.
Sci Rep
; 13(1): 17337, 2023 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37833554
4.
Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults.
J Clin Invest
; 133(13)2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37219944
5.
Favorable vaccine-induced SARS-CoV-2-specific T cell response profile in patients undergoing immune-modifying therapies.
J Clin Invest
; 132(12)2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35536644
6.
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines.
Cell Rep Med
; 3(11): 100793, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257326